| Title : Effect of Rivastigmine (Acetyl Cholinesterase Inhibitor) versus Placebo on Manic Episodes in Patients with Bipolar Disorders: Results from a Double Blind, Randomized, Placebo-Controlled Clinical Trial - Keshavrzi_2019_Neuropsychobiology__1 |
| Author(s) : Keshavrzi A , Rezaei H , Haghighi M , Jahangard L |
| Ref : Neuropsychobiology , :1 , 2019 |
| Abstract : Keshavrzi_2019_Neuropsychobiology__1 |
| ESTHER : Keshavrzi_2019_Neuropsychobiology__1 |
| PubMedSearch : Keshavrzi_2019_Neuropsychobiology__1 |
| PubMedID: 31315114 |
Keshavrzi A, Rezaei H, Haghighi M, Jahangard L (2019)
Effect of Rivastigmine (Acetyl Cholinesterase Inhibitor) versus Placebo on Manic Episodes in Patients with Bipolar Disorders: Results from a Double Blind, Randomized, Placebo-Controlled Clinical Trial
Neuropsychobiology
:1
Keshavrzi A, Rezaei H, Haghighi M, Jahangard L (2019)
Neuropsychobiology
:1